Autizmus spektrumzavar: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• PTEN 2
• mTOR 0
• BDNF 0
• NMDA 0
• CTNNB1 1
• AKT 0
• SCN2A 0
• PI3K 0
• PPAR 0
• NRF2 0
• IL-6 0
• IL-17 0
• JAK 0
• NF1 0
• STAT3 0
• ERK 0
• NLRP3 0
• TREM2 0
• AMPK 0
• BCL-2 0
• DMD 0
• FTO 0
• IL-1 0
• SIRT1 0
• TLR4 0
• TP53 0
• APOE 0
• CD38 0
• CFTR 0
• COX-2 0
• G6PD 0
• GLP-1 0
• HDAC 0
• HER2 0
• HIF-1 0
• HMGB1 0
• KMT2A 0
• MAPK 0
• MMP-9 0
• PDGFR 0
• PKD1 0
• RANKL 0
• SCN1A 0
• TDP-43 0
• TNF 0
• VEGF 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  SYmbiotic Microbiota of honey Bees: Influence On Social communication (SYMBIOS)

  Universite de Geneve· Geneve, Svájc· EU contribution 307 959 EUR· until 2029. jan.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Simulating Other Minds in Autism (MINDSIM)

  Karolinska Institutet· Stockholm, Svédország· EU contribution 1 500 000 EUR· until 2031. dec.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  DEcoding Contextual Inference of Priors in Human pERception (DECIPHER)

  Universita Degli Studi di Firenze· Florence, Olaszország· EU contribution 317 923 EUR· until 2029. okt.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  High-throughput screen for disfunctions in GABA-switch in human neuronal models of SNAREopathies

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 247 553 EUR· until 2028. okt.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Tuning claustrum circuits to restore cognitive function (CLAUSTUNE)

  Universite de Geneve· Geneve, Svájc· EU contribution 150 000 EUR· until 2028. márc.

  The disease is named only in the funder's project summary, not in the title.

5 of 59 running projects, newest first. Listed amounts together: 166,0 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 16
• Organoids 21
• Mendelian Randomization Analysis 26
• CRISPR-Cas Systems 8
• Gene Expression Profiling 44
• Sequence Analysis, RNA 3
• Whole Genome Sequencing 7
• Exome Sequencing 52
• Proteomics 26
• Metabolomics 20
• Mass Spectrometry 7
• Immunohistochemistry 4
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 239
• Machine Learning 80
• Deep Learning 37
• Cohort Studies 134
• Genome-Wide Association Study 52

• Whole-Exome Sequencing in Patients with Tooth Agenesis and Neurodevelopmental Disorders: A Descriptive Case Series.

  Int J Mol Sci, 2026. okt.

• Diagnostic Yield and Clinical Actionability of Genetic Testing in Neurodevelopmental Disorders: A Systematic Review and Meta-Analysis.

  Int J Mol Sci, 2026. okt.

• Whole-exome sequencing in a Turkish autism spectrum disorder cohort: a retrospective study of molecular diagnostic yield in isolated and complex presentations.

  BMC Psychiatry, 2026. okt.

• KATNAL2 dysfunction impairs microtubule dynamics and contributes to syndromic neurodevelopmental disease.

  Hum Mol Genet, 2026. okt.

• [Genetic and phenotypic analysis of three children with Neurodevelopmental disorders due to variants of DEAF1 gene].

  Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2026. okt.

• Phenotypic Complexity and Diagnostic Utility of Exome Sequencing in ASD: Real-World Insights from Colombia.

  Int J Mol Sci, 2026. okt.

• Clinical Utility of Trio Exome Sequencing in Rwandan Children With Autism Spectrum Disorder.

  Mol Genet Genomic Med, 2026. szept.

• De Novo ZNF292 Variants Cause Neurodevelopmental Disorder with Short Stature: A Clinical Case Series of Eight Individuals.

  Genes (Basel), 2026. aug.

• A De Novo DHX16 Variant Associated With Neuromuscular Oculoauditory Syndrome Regulates Pre-mRNA Splicing In Vitro.

  Clin Genet, 2026. aug.

• Genetic Heterogeneity in Autism Spectrum Disorder: Diagnostic Yield, Recurrent Genes, and Rare Variant-Phenotype Associations from Whole-Exome Sequencing.

  Int J Mol Sci, 2026. aug.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.